Sugar Editorial Picks
Feb 25, 2009 -
This week is National Eating Disorder Awareness Week, and since as many as 10 million females and one million males in the US are suffering from an eating disorder, I'm thankful that we have resources such as the National Eating Disorders Association. Their main goal is to raise awareness, educate, support, and eventually help eradicate eating disorders altogether.
Body image issues are common all over the world and they can easily manifest in an eating disorder so I'm curious to see how many of you have either suffered from one yourself, or known someone that has.
- 34 Comments
Feb 24, 2009 -
National Eating Disorders Awareness Week encourages eating disorder sufferers to get help and educates the public. Some of you are all too aware of them, whether you've personally suffered or watched someone close to you.
Part of raising awareness is speaking out.
- 64 Comments
Feb 26, 2007 -
I want to make you all aware that it is National Eating Disorder Awareness Week. Eating disorders are serious issues and there are a lot of folks out there suffering. Most of us have heard of anorexia and bulimia, but MSNBC recently reported that binge eating is the most common eating disorder in the US.
- 5 Comments
Other Search Results
Feb 23, 2009 -
This may not be a sunny, happy topic, but it needs to be discussed. In fact, it merits an entire week of discussion, if not more. It is National Eating Disorders Awareness Week.
- 11 Comments
Feb 25, 2008 -
This may not be a sunny, happy topic, but it needs to be discussed. In fact, it merits an entire week of discussion. It is National Eating Disorders Awareness Week.
- 1 Comment
Oct 08, 2008 -
In This Report
- Highlights
- Introduction
- Causes
- Risk Factors
- Complications
- Diagnosis
- Treatment
- Medications
- Other Treatments
- Resources
- References
HEALTH GUIDE REFERENCE FROM A.D.A.M
Highlights
Drug Approval
In 2007, duloxetine (Cymbalta) was approved for treatment of generalized anxiety disorder. Duloxetine is a dual inhibitor antidepressant.
Anxiety Disorders Under-Recognized and Under-Treated
About 41% of patients with an anxiety disorder do not receive any treatment, indicates a 2007 study in the Annals of Internal Medicine.
- 1 Comment
Oct 08, 2008 -
In This Report
- Highlights
- Introduction
- Risk Factors
- Causes
- Complications of Bulimia...
- Complications of Anorexia...
- Symptoms
- Diagnosis
- Treatment
- Treatment for Bulimia
- Treatment for Anorexia
- Therapy
- Resources
- References
HEALTH GUIDE REFERENCE FROM A.D.A.M
Highlights
Eating Disorders Overview
- Eating disorders typically occur among young women.
- Bulimia nervosa involves a pattern of bingeing and purging. Many people with bulimia nervosa also suffer from depression.
- Anorexia nervosa involves a pattern of self-starvation. Patients often have an accompanying anxiety disorder (such as obsessive compulsive disorder) or depression.
- 1 Comment
Oct 08, 2008 -
In This Report
- Highlights
- Introduction
- Risk Factors
- Causes
- Diagnosis
- Other Disorders Associated ...
- Complications
- Treatment
- Medications
- Behavioral Management
- Other Treatments
- Resources
- References
HEALTH GUIDE REFERENCE FROM A.D.A.M
Highlights
Drug Approval
In 2007, the Food and Drug Administration (FDA) approved lisdexamfetamine (Vysvanse), a new stimulant drug for the treatment of attention-deficit/hyperactivity disorder (ADHD). The active ingredient in lisdexamfetamine is similar to dextroamphetamine, the drug used in Dexedrine and Adderall.
Drug Warning
In 2007, the FDA instructed the manufacturers of all ADHD drugs to include drug warning labels describing the risks for heart and psychiatric side effects.
- 0 Comments
Oct 08, 2008 -
In This Report
- Highlights
- Introduction
- Causes
- Risk Factors
- Complications of Depression...
- Diagnosis
- Treatment
- Antidepressants and Drug Tr...
- Psychotherapy
- Other Treatments
- Lifestyle Changes
- Resources
- References
HEALTH GUIDE REFERENCE FROM A.D.A.M
Highlights
Drug Approval
In 2007, the Food and Drug Administration (FDA) approved the atypical antipsychotic drug aripiprazole (Abilify) for treatment of major depression in adults. Aripiprazole is used for treatment of schizophrenia and bipolar disorder. For depression, it is used in combination with antidepressant drug therapy.
- 5 Comments
Oct 08, 2008 -
In This Report
- Highlights
- Introduction
- Causes of Short-Term or Tra...
- Causes of Chronic Insomnia...
- Risk Factors
- Prognosis
- Diagnosis
- Treatment
- Medications
- Resources
- References
HEALTH GUIDE REFERENCE FROM A.D.A.M
Highlights
Sedative Hypnotic Drug Warnings
In March 2007, the FDA ordered stronger warning labels on sedative hypnotic drugs. These medications include benzodiazepine and non-benzodiazepine drugs, such as zolpidem (Ambien), eszopiclone (Lunesta), ramelteon (Rozerem), and triazolam (Halcion). The FDA warned that these drugs may be associated with:
- Severe allergic reactions (anaphylaxis) and severe facial swelling (angioedema), which can occur even the first time a drug is taken
- Complex sleep-related behaviors, such as sleep driving, making phone calls, and preparing and eating food while asleep
Patients who take sleeping pills should be sure to follow the directions.
- 5 Comments